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Objectives: The aimof this study is to gain insight into themechanismof the antimicrobial action of a novel
arginine-based surfactant, bis(Na-caproyl-L-arginine)-1,3-propanediamine dihydrochloride [C3(CA)2].
Methods: To this end, we compared its effects against Staphylococcus aureus and Escherichia coli with
those caused by the commercial and widely known antiseptic, chlorhexidine dihydrochloride (CHX).
Results: Both disrupted the cell membrane of the target bacteria to cause potassium leakage and
morphological damage. The effect of C3(CA)2 on E. coli was concentration dependent, causing loss
of membrane potential and membrane integrity leading to cell death, whereas CHX did not have these
effects on E. coli. The effect of C3(CA)2 on S. aureuswas the formation of mesomes and cytoplasmic clear
zones, but the loss of membrane potential and membrane integrity was slightly lower than that with CHX.
Conclusions: We propose that C3(CA)2 acts preferentially against Gram-negative bacteria through strong
initial binding to the surface lipopolysaccharides and subsequently partitioning into the cell membrane
to cause membrane damage, followed by cell death.
Keywords: antimicrobial activity, flow cytometry, viability reduction, transmission electron microscopy, potassium
leakage, cationic surfactants
Introduction
Arginine-based cationic surfactants are amphiphilic compounds
that possess excellent self-assembling properties, a low toxicity
profile, high biodegradability and a broad antimicrobial
activity, which make them candidates of choice as preservatives
and antiseptics in pharmaceutical, food and dermatological
formulations.1–5 Among the arginine-based surfactants synthesized
in our laboratory, bis(Na-caproyl-L-arginine)-1,3-propanediamine
dihydrochloride [C3(CA)2] is a novel gemini (double-chain/
double-polar head) compound which shows antimicrobial activity
against a wide range of Gram-positive and Gram-negative
bacteria.1,6
Bacterial cells offer three regions for biocide interaction: the
cell wall, the cytoplasmic membrane and the cytoplasm. In
general, microbicides lack target specificity, though in the case
of biguanide compounds such as chlorhexidine dihydrochloride
(CHX), and cationic surfactants, their main target is the bacterial
membrane.7–10 Both biguanides and cationic surfactants have a
similar mechanism of action.11 As shown in Figure 1, both com-
pounds are dicationic but with different structures: C3(CA)2 has
two arginine residues connected by three methylene groups, and
two alkyl chains of ten carbon atoms that form the hydro-
phobic moieties. CHX, on the other hand, possess two biguanides
as the polar heads connected by a spacer chain of six methylenes,
and two chloro-phenyl groups as the hydrophobic core.
These cationic compounds initiate their interaction with the
cytoplasmic membrane by binding to the phospholipid surface
through electrostatic forces. They are then absorbed in the
hydrophobic core of the membrane perturbing the packing of
the lipids, leading to dissolution of the proton motive force
and leakage of essential molecules.8,10 The specificity of these
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compounds towards prokaryotes, rather than eukaryotes, is thought
to be due to the higher amount of anionic phospholipids in proka-
ryotic membranes.12–14
The synthesis of new biocompatible (i.e. low toxicity profile
and high biodegradability) powerful antimicrobial agents is of
paramount importance to prevent infectious diseases.10,15 The
design of new molecules can be aided by an understanding of
their mechanism of action, and we have recently reported the
interaction of arginine-based surfactants with biomembrane
models (i.e. liposomes and phospholipid monolayers).6 The
purpose of this work is to elucidate the effects of the gemini sur-
factant C3(CA)2 on cell viability and on cell envelope integrity in
Staphylococcus aureus and Escherichia coli. The well known
biguanide CHX was included in these studies for comparison.
Materials and methods
Antibacterial products and chemicals
C3(CA)2 was synthesized in our laboratory as previously described.
3,16
CHX was purchased from Sigma (St Louis, MO, USA). Molecular
dyes Syto-13, propidium iodide (PI) and bis-1,3-dibutylbarbutiric acid
(bis-oxonol) were supplied by Molecular Probes Europe BV (Leiden,
The Netherlands). The solvents and reagents used were of analytical
grade. Ultra pure water, produced by a Nanopure purification
system coupled to a Milli-Q water purification system, resistivity =
18.2 M·W·cm, was used for the aqueous solutions.
Microorganisms
Strains were obtained from the American Type Culture Collection
(ATCC; Manassas, VA, USA): S. aureus ATCC 9144 and E. coli
ATCC 10536. They were sub-cultured weekly on trypticase soy
agar (TSA; Pronadisa, Barcelona, Spain). Strains were maintained
frozen in cryovials (AES Laboratoire, Combourg, France) at –80C.
MICs
The MICs of C3(CA)2 and CHX were determined by using a broth
micro-dilution assay.17 Briefly, serial dilutions of the antimicrobials
were made in Mueller–Hinton broth (Oxoid, USA). A 96-well poly-
propylene microtitre plate (Costar, Corning Incorporated, Corning,
NY, USA) was used. Each well was inoculated with 100 mL of the
test organism in Mueller–Hinton broth to a final concentration of
105 cfu/mL. The MIC was taken as the lowest antimicrobial concen-
tration at which growth was inhibited after 24 h of incubation at 37C.
Exposure of microorganisms to biocides
Suspensions of the microorganisms were obtained from an overnight
culture of each strain on tryptone soy broth (TSB) (Oxoid, USA) at
30C. Cultures were then centrifuged at 8000 g for 15 min, washed
twice in sterile Ringer’s solution (Scharlau, Barcelona, Spain) and
resuspended in Ringer’s solution to obtain a cell suspension of
about 107–108 cfu/mL. Three millilitres of the respective cell suspen-
sions was used to inoculate flasks containing 27 mL of Ringer’s solu-
tion to obtain a cell density of about 106–107 cfu/mL.
Different aliquots (7.5–360 mL, depending on the final 1/2 or 3/2
MIC) of the stock solution of C3(CA)2 and CHX (see Table 1) were
added to flasks with the respective bacterial suspensions.
After a contact time of 30 min, the biocide effect was immediately
neutralized by dilution with sterile Ringer’s solution, then the
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Figure 1. Structures of the selected antimicrobial compounds.
Table 1. Minimum inhibitory concentration in mg/L and the
antimicrobial concentrations tested
S. aureus E. coli
Compound MIC 1/2 MIC 3/2 MIC MIC 1/2 MIC 3/2 MIC
C3(CA)2 2 1 3 8 4 12
CHX 0.5 0.25 0.75 2 1 3
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bacterial suspension was centrifuged for 20min at 8000 g and the pellet
was resuspended with Ringer’s solution to obtain the convenient cell
suspension concentration (107–108 cfu/mL). The inoculated
flasks were kept at room temperature.
For flow cytometry (FC) experiments, 15 mL samples were diluted,
centrifuged at 8000 g for 30 min and the bacterial pellets were resus-
pended in 1 mL of Ringer’s solution.
For transmission electronic microscopy (TEM) observations,
the contact time was 30 min at biocide concentration 3/2 MIC.
Then, samples of 5 mL were taken, diluted with Ringer’s
solution and centrifuged at 4500 g for 30 min. The bacterial pellets
were then rinsed with 0.1 M phosphate buffer (pH 7.4).
In all cases, control experiments lacking microbicide were
conducted in parallel.
Staining procedure
Staining protocols for FC experiments were as follows: 1 mL of a
500 mM stock solution of Syto-13 in dimethyl sulphoxide and 10 mL
of a 1 mg/mL stock solution of PI in distilled water were added to
500 mL of the bacterial suspension in filtered Ringer’s solution. The
S. aureus and E. coli suspensions were incubated with the dyes for 3
and 20 min, respectively. Stains were performed at room temperature
before the FC analysis. Experiments were conducted in triplicate.
In the case of the membrane potential dye, 2 mL of a 250 mM stock
solution of bis-oxonol in ethanol was added to 500 mL of the bacterial
suspension to a final concentration of 1 mM and incubated for 2 min.
Cells killed by heat exposure (30min at 70C)were used as controls for
bis-oxonol staining. Experiments were conducted in duplicate.
Flow cytometry (FC)
A Coulter Epics Elite flow cytometer (Coulter Corporation, Florida,
USA) equipped with a 15 mW air-cooled 488 nm argon-ion laser (for
Syto-13, PI and bis-oxonol excitation) was used. The green emission
from Syto-13 and bis-oxonol was collected through a 525 nm
band-pass filter. The red emission from PI was collected with a
675 nm band-pass filter. Although the maximum emission is at
620 nm, a 675 nm band-pass filter was used to minimize interference
with the strong fluorescence of Syto-13.
Bacteria were counted using a Cytek Flow Module (Cytek
Development, CA, USA) adapted to the flow cytometer. Forward,
side-scatter and fluorescence signals were collected in logarithmic
scale. A significant percentage of the bacterial population that can
be detected by its Syto-13 fluorescence appears in the first channel
of the scatter. Consequently, fluorescence is used to discriminate
bacteria rather than scatter, thus obtaining a better resolution and
decreasing the background. Data were analysed with Elitesoft version
4.1 (Coulter Corporation) and WinMDI version 2.8 software.
Particle size analysis
Cell suspensions were analysed with a Multisizer II (Coulter) using a
30 mm aperture. Cell suspensions were diluted (1/1000) in 0.9% NaCl
previously passed through a 0.2 mm filter. Data were analysed by
AccuComp software version 1.15 (Coulter).
Bacterial count
Viable counts (cfu/mL) were obtained on trypticase soy agar (TSA).
After an appropriate dilution in Ringer’s solution, the sample was
inoculated on plates and incubated at 30C for 24–48 h. Rapid
separation of bacteria from the antimicrobial was achieved by centri-
fugation at 4500 g in a bench top centrifuge for 15 min and subsequent
dilution in Ringer’s solution prior to plating. Cell counting was
performed in triplicate.
Transmission electron microscopy (TEM)
After treatment of cell suspensions with the biocides at 3/2 MIC for
30 min for each microorganism [3 and 12 mg/L of C3(CA)2 with
S. aureus and E. coli, respectively, and 0.75 and 3 mg/L of CHX
with S. aureus and E. coli, respectively] the bacterial pellets were
rinsed with 0.1 M phosphate buffer (pH 7.4), washed three times
and fixed with 2.5% buffered glutaraldehyde for 1 h at 4C. The
cells were then post-fixed in 1% buffered osmium tetroxide for 1 h,
stained with 1% uranyl acetate, dehydrated in a graded series of
ethanol, and embedded in LR (London Resin Co. Ltd, London, UK)
white resin. Ultra-thin sections were prepared and stained with 1%
uranyl acetate and sodium citrate. Microscopy was performed with a
Philips EM 30 (Eindhoven, Holland) microscope with an acceleration
of 60 kV.
Potassium leakage
Potassium leakage was measured as described previously.4 Cells were
grown on TSA at 37C for 12 h, then harvested in 10 mL of Ringer’s
solution, washed three times with Ringer’s solution and finally cent-
rifuged at 5000 g for 30min at 15C and resuspended in 25mL of 1mM
glycil-glycine buffer solution pH 6.8 to obtain a cell density of 2 · 108
cfu/mL and 3 · 108 cfu/mL for S. aureus and E. coli, respectively. The
microorganisms were treated with the antimicrobials at 3/2 MIC for
30 min. Then, 5 mL of cell suspension was removed, diluted and
centrifuged at 4500 g for 15 min. Positive controls were lysed cell
suspension obtained by thermal shock (70C for 30 min). Experiments
were conducted in triplicate.
The potassium concentration in the supernatant was measured
using an atomic absorption Philips PU9200X spectrophotometer (Phi-
lips Cambridge, UK). Absorbance values were converted into potas-
sium ion concentration (ppm) by reference to a curve using potassium
ion solution of 0, 0.1, 0.2, 0.5 and 1 ppm.
Results
As shown in Table 1, the MICs of C3(CA)2 and CHX for S. aureus
were 2 and 0.5 mg/L, respectively, and those for E. coli were 8 and
2 mg/L, respectively. To study the effect of the antimicrobial
agents on the bacterial population, two concentrations were
selected on an MIC basis: the first was 50% greater than the cor-
responding MIC (3/2 MIC) and the second was 50% lower than the
MIC (1/2 MIC). The concentrations of the surfactant, C3(CA)2,
were always lower than the corresponding critical micellar con-
centration (i.e. 4 · 10–5 M).18
Flow cytometry (FC) and viability reduction
To assess the effect of C3(CA)2 and CHX on bacterial populations,
dual staining of cells was performed with Syto-13 (a nucleic acid
stain that penetrates all types of cellular membranes) and
PI, a nucleic acid stain not taken up by intact cells.19 Hence,
three types of stained cells could be observed after the treatment:
cells stained with Syto-13 (intact cells), double stained cells (par-
tially damaged cells) and cells stained with PI (severely damaged
cells).
To validate the FC results, and to examine the putative rela-
tion between cell damage and cell viability, viable cell counts
were determined after exposure to the microbicides. The results
with S. aureus are shown in Figure 2(a–c) and Table 2. As seen
in Figure 2(a), the control population was mainly stained with
Syto-13 (99 – 1%). After 30 min of contact with 3 mg/L (3/2
MIC) C3(CA)2, 95 – 1% of the cells were stained with Syto-13,
Comparative study of the antimicrobial activity of C3(CA)2
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2 – 1% were double stained and 3 – 1% were stained with PI,
indicating slight damage caused by C3(CA)2. Varying the C3(CA)2
concentration did not alter the proportion of damaged cells (Table 2,
entries 2 and 3). Likewise, cell counts on plates did not change
substantially with biocide concentration; viable cells dropped from
79 – 10% at 1 mg/L (1/2 MIC) to 69 – 6% at 3 mg/L (3/2 MIC).
When S. aureus was treated with 0.75 mg/L CHX (3/2 MIC)
(Figure 2c), 11 – 4% partially damaged (double stained), and
15 – 1% severely damaged cells (PI stained cells) were seen.
Decreasing the biocide concentration from 3/2 to 1/2 MIC did
not affect the proportion of partially damaged cells, since double
stained cells only decreased from 11 – 4 to 5 – 1% (Table 2, entries
4 and 5). These results agree with the cell counts, where varying
biocide concentration caused only a slight effect on cell viability
(Table 2, entries 4 and 5).
A different pattern was observed in E. coli populations when
theywere treatedwithC3(CA)2 andCHX (Figure 2d–f andTable 3).
The control population showed 91 – 4% of intact cells (stained
by Syto-13). After treatment with 12 mg/L C3(CA)2 (3/2 MIC),
a dramatic decrease in intact cells was detected, only 5 – 1% of
the population retained Syto-13 whereas 77 – 10% were severely
damaged (stained by PI), and the remaining 18 – 3% were partially
damaged (double stained, Figure 2e). At 4 mg/L C3(CA)2
(1/2 MIC), 42% (PI and PI + Syto-13) of the population showed
signs of damage and the reduction in viabilitywas 77– 1% (Table 3,
entry 2). Three sub-populations could clearly be observed
(Figure 2f) when E. coli cultures were treated with CHX at
3/2 MIC: 63 – 5% remained intact (Syto-13); 21 – 2% showed
partial damage (double stained); and 16 – 3% of cells were
severely damaged (stained by PI). As presented in Table 3 (entries
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Figure 2. Effect on the membrane integrity of S. aureus and E. coli caused by exposure to C3(CA)2 and CHX, shown by dual staining with PI and Syto-13.
(a) Untreated S. aureus control, (b) S. aureus treated with C3(CA)2, (c) S. aureus treated with CHX, (d) untreated E. coli control, (e) E. coli treated with C3(CA)2,
and (f) E. coli treated with CHX. In all cases, time of contact was 30 min and antimicrobial concentration was 3/2 MIC.
Table 2. Effect of the antimicrobials on S. aureus after a dual stain with PI and Syto-13, and viability by plate counts
Entry Sample Conc. (mg/L) Syto-13 (%) PI + Syto-13 (%) PI (%) cfu/mL (106) Viability reduction (%)
1 control – 99 – 1 0 1 – 1 4.8 – 1.3 –
2 C3(CA)2 1 93 – 3 4 – 1 3 – 2 3.8 – 1.3 21 – 10
3 C3(CA)2 3 95 – 1 2 – 1 3 – 1 3.3 – 0.6 31 – 6
4 CHX 0.25 80 – 7 5 – 1 14 – 4 3.8 – 3.3 21 – 13
5 CHX 0.75 74 – 8 11 – 4 15 – 1 3.4 – 2.1 29 – 9
Antimicrobial concentrations tested were 1/2 MIC and 3/2 MIC, and time of contact was 30 min. Data are given as the mean – SEM of three separate experiments.
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4 and 5), variation of CHX concentration did not appear to have
any effect as observed by FC; the population stained by Syto-13
decreased from 67 – 5 to 63 – 5%. However, the viability
reduction changed significantly with CHX concentration, from
44 – 1 to 61 – 1 (i.e. 17 – 2% of viability reduction).
Membrane potential
Membrane depolarization was measured by determining the relat-
ive fluorescence intensity of bis-oxonol labelling using FC. As
shown in Figure 3, the negative controls (i.e. cell suspensions in
the absence of microbicides) showed the minimum relative fluor-
escence intensity (Figure 3a and e). We considered the range M1
[0-350 fluorescence units (FU)] as undamaged cells showing no
significant depolarization of the cytoplasmic membrane. As expec-
ted, the positive control (i.e. bacteria that underwent a thermal
shock at 70C for 30 min) showed the maximum relative fluores-
cence intensity (Figure 3d and h). We considered the range M2
(between 350 and 1024 FU) as damaged and dead cells. The effect
of C3(CA)2 on S. aureus showed a bimodal profile (Figure 3b) with
two distinct populations of cells: almost 50% of the population
emitted fluorescence in the region of non-damaged cells; while the
rest emitted in the region of the dead cells. A different pattern was
observed on exposure of E. coli to C3(CA)2; 84% of cells were
damaged or dead (increased fluorescence); and 16% remained
intact. When cells were exposed to CHX, a bimodal pattern was
observed (i.e. 49% intact and 51% damaged cells) with E. coli
(Figure 3g), whereas, for the most part, S. aureus was undamaged
(Figure 3c).
Potassium ion leakage
Potassium ion (K+) leakage reflects an increase in the cytoplasmic
membrane. Here, intracellular potassium leakage resulting from
exposure to C3(CA)2 and CHX of S. aureus and E. coli at the
corresponding 3/2 MIC was measured. The cell density was
2 · 108 and 3 · 108 cfu/mL for S. aureus and E. coli, respectively.
The negative blank was the K+ leakage measured from the bacterial
suspensions in the absence of the antimicrobials (363 – 75 ·
10–3 ppm K+ from S. aureus and 769 – 42 · 10–3 ppm K+ from
E. coli). The positive blank was the K+ released from the bacterial
suspensions heated at 70C for 30 min (509 – 29 · 10–3 ppm K+
from S. aureus and 918 – 33 · 10–3 ppm K+ from E. coli). Thus,
the percentage of K+ leakage was the ratio of net to total amount
of K+ released.
Experiments with the Gram-positive organism showed that
C3(CA)2 caused a potassium loss of 401 – 32 · 10–3 ppm K+
(26%) and CHX 375 – 63 · 10–3 ppm K+ (8%). The results
with the Gram-negative organism showed that both antimicrobials
released higher amounts of potassium ion than the Gram-positive
organism: the surfactant, C3(CA)2, released 951 – 52 · 10–3 ppm
K+ (>100%) and CHX released, 889 – 42 · 10–3 ppm K+ (81%).
TEM
Mesosome-like structures (i.e. spiral-bodies of the cytoplasmic
membrane forming within the cytoplasm) and some cytoplasmic
clear zones could be seen in S. aureus treated with C3(CA)2
(Figure 4a). In the case of E. coli more severe perturbations
could be seen; numerous vesicles protruded from around the
cell, severe damage to the membranes, appearance of cytoplasmic
white spots, and abnormal septation (Figure 4b). The morpholo-
gical disturbance caused by CHX on S. aureus was mesosome
formation, clear zones and membrane-like convoluted structures
in the cytoplasm (Figure 4c). In E. coli, cytoplasmic damage was
clearly seenwith the appearance of cytoplasmic white spots, as well
as clear zones, and perturbations of the cytoplasmic membrane
(Figure 4d).
Discussion
C3(CA)2, and the comparator molecule CHX, change the polarity
of the cell membrane bilayer of the bacteria and cause leakage of
K+ ions from the cytoplasm. Both phenomena are involved in the
cell death mechanism. But, these two compounds have different
bacterial selectivity suggesting a different mode of action; C3(CA)2
has a concentration dependent microbicidal effect on E. coli, but
has little effect on S. aureus; whereas CHX has little effect on
E. coli, and does cause some damage (though not loss of viability)
to S. aureus.
Potassium leakage is a first indication of membrane damage
in microorganisms.20–22 Ultrastructural changes are also observed
early on in the progress of membrane damage, with mesosome-
like structures often appearing before any other effects on cell
viability are noted.23 Both C3(CA)2 and CHX induced the first
stages of cytoplasmicmembrane damage inE. coli and in S. aureus,
as shown by loss of intracellular potassium ions from washed
cell suspensions, and the presence of intracellular mesosomes.
This may be due to both the physicochemical properties of
the microbicides and the composition of the cell membrane of
Gram-positive and Gram-negative bacteria.7 Both, C3(CA)2 and
CHX have two negative charges but the former is an amphiphilic
molecule with surfactant properties whereas the later has a weak
surface activity.6,24,25
The fluorochromes PI and Syto-13 were chosen because of
their potential ability to distinguish between intermediate states
of dead and live cells; PI confers fluorescence on cells which
Table 3. Effect of the antimicrobials on E. coli after a dual stain with PI and Syto-13, and viability by plate counts
Entry Sample Conc. (mg/L) Syto-13 (%) PI + Syto-13 (%) PI (%) cfu/mL (106) Viability reduction (%)
1 control – 91 – 4 3 – 1 6 – 3 2.5 – 1.5 –
2 C3(CA)2 4 58 – 11 15 – 2 27 – 3 0.6 – 0.3 77 – 1
3 C3(CA)2 12 5 – 1 18 – 3 77 – 10 0.1 – 0.1 95 – 1
4 CHX 1 67 – 5 13 – 2 20 – 3 1.4 – 0.8 44 – 1
5 CHX 3 63 – 5 21 – 2 16 – 3 1.0 – 0.4 61 – 1
Antimicrobial concentrations tested were 1/2 MIC and 3/2 MIC, and time of contact was 30 min. Data are given as the mean – SEM of three separate experiments.
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Figure 3. Effect on the transmembrane potential of S. aureus and E. coli caused by exposure to C3(CA)2 and CHX, shown by bis-oxonol staining. The relative
fluorescence intensities within the M1 regions were taken as live cells, and those within the M2 regions were take as dead cells (logarithmic scale). (a) Untreated
S. aureus control, (b) S. aureus treated with C3(CA)2, (c) S. aureus treated with CHX, (d) S. aureus heated at 70
C, (e) untreated E. coli control, (f) E. coli treated
with C3(CA)2 (g) E. coli treated with CHX, and (h) E. coli heated at 70
C. In all cases, time of contact was 30 min and antimicrobial concentration was 3/2 MIC.
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have lost their membrane integrity, whereas Syto-13 confers
fluorescence on intact cells. The fluorochrome bis-oxonol is an
anionic lipophilic dye that does not accumulate to any great extent
in cells with a negative transmembrane potential, and fluorescence
increases as membrane potential decreases.26 These labels, in
combination with ultrastructural studies, and cell viability assays
demonstrated marked differences between the microbicides in
their action on the bacterial cells: when E. coli was exposed to
C3(CA)2, 84% showed loss of membrane potential, 27–77% of
cells showed membrane damage and 77–95% loss of cell viability,
depending on the concentration of C3(CA)2 used. It is remarkable
that the bis-oxonol fluorescence measured from the C3(CA)2-
treated E. coli was close to that of the positive control. This
indicates a complete membrane depolarization that caused irre-
versible damage leading to loss of viability. Electron micrographs
agree with these results. Intracytoplasmic black spots were
observed, similar to those reported in E. coli heat-treated cells.27
The most striking ultrastructural effect observed in E. coli was the
formation of vesicles blebbing out from the outer membrane in the
presence of C3(CA)2, similar to those reported for benzal-
konium chloride-treated Pseudomonas aeruginosa.28 CHX had
little effect on E. coli membrane integrity, shown by PI and
Syto-13 labelling, though some intracytoplasmic changes were
observed by electron microscopy. A moderate effect on E. coli
membrane potential (51%) and cell viability (61% reduction)
were also observed.
S. aureus membranes seem to be little affected by exposure of
the bacteria to C3(CA)2, with just 5–7% loss of integrity shown by
PI staining; a low emission of bis-oxonol fluorescence, indicating a
moderate effect on the membrane potential and a low impact on the
viability of the cells. Exposure to CHX caused some loss of mem-
brane integrity (the proportion of PI stained cells increased), and a
moderate reduction in membrane potential, but no reduction in
viability. These data were supported by ultrastructural studies.
These data are consistent with the idea that C3(CA)2 and CHX
are probably working through similar overall mechanisms, but
with different bacterial specificities due to their charge properties
and the nature of the bacterial targets: Gram-negative cells offer a
lipopolysaccharide (LPS) barrier that Gram-positive cells do not
posses.7 The anionic character of the LPS layer14 could enhance the
binding of the cationic surfactant C3(CA)2, which would not be so
strong with CHX due to its weak surface activity and surfactant
properties. This, together with the ability of C3(CA)2 to partition
between the aqueous solution and the biological membrane,
would make it an excellent molecule for targeting Gram-negative
bacteria.
A lack of correlation between the membrane damaging action
and cell viability seen for S. aureus suggests that membrane
perturbation may be an important step in cell death, but is not
necessarily a lethal event. Previous studies with S. aureus and
E. coli have also indicated that membrane perturbation caused
by antimicrobials and recovery of cells on agar are not always
(a)
100 nm
100 nm
500 nm 1000 nm
1 nm
200 nm
200 nm
(b)
(c) (d)
Figure 4. Effect on membrane ultrastructure of S. aureus and E. coli caused by exposure to C3(CA)2 and CHX, shown by transmission electron microscopy.
(a) S. aureus treatedwith C3(CA)2, (b)E. coli treatedwith C3(CA)2, (c) S. aureus treatedwith CHX, and (d)E. coli treatedwith CHX. In all cases, time of contact was
30 min and antimicrobial concentration was 3/2 MIC.
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directly related.4,29 This may be due to technical factors such as
the conditions for recovery of cells;8,30,31 or that membrane
perturbation does not necessarily lead to dissolution of the proton
motive force and cell death.8,30,31
It is notable that two different populations (50%) were
registered using the bis-oxonol dye. This points to the presence
of sub-populations with different degrees of damage, suggesting
reversible damage or it could even represent viable and non-viable
organisms.32
Conclusions
C3(CA)2 and CHX induce similar types of damage to S. aureus
and E. coli, though they differ in the extent of membrane depol-
arization and reduction in cell viability. These differences suggest
that both compounds damage bacteria in a different way, and that
the surfactant properties of C3(CA)2 and its ability to partition
into the biological membrane from aqueous solution might be
important characteristics in its microbicidal action.
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